Drug patents don’t necessarily spur companies to innovate so much as restrict access to their IP.
Andrii Zastrozhnov/iStock via Getty Images Plus
The Medicines Patent Pool was created to promote public health, facilitating generic licensing for patented drugs that treat diseases predominantly affecting low- and middle-income countries.
Changes in the latest federal budget will mostly affect people who need multiple medicines throughout the year, perhaps for chronic disease. But there are other ways to reduce drug costs.
Generic drug names are assigned at the global level by the World Health Organization in conjunction with national naming authorities.
Generic drug names are often long, but they can tell doctors what type of medicine it is and how it works. But it’s brand names that appear first and most prominently in Health Canada materials.
Peter Dazeley/Getty Images
There are ingredients in your pills other than the one designed to treat your ailments. Those unnamed ingredients can alter how you respond to a medicine or even make you sick.
The pipeline of pharmaceuticals is easily disrupted.
Gumpanat/iStock via Getty Images Plus
Drug shortages occur regularly in the US, even in the best of times. The pharmaceutical supply chain embodies ‘just in time’ shipping and has little built-in redundancy.
Research shows that the number of drug shortages in Canada are increasing, even though patients may not be aware of it.
The Canadian government must undertake regular analysis of the drug shortage problem, if we are ever to develop sustainable solutions.
The case for academic-industry collaboration.
Teamwork image via www.shutterstock.com.
Academics are trained to answer important questions about health policy, and collaborating with industry on research can have a big impact.
Representatives of the 12 Trans-Pacific Partnership (TPP) member countries at a press conference in Atlanta, after a deal was reached.
EPA/Erik S. Lesser
Before the last round of negotiations, only a handful of issues remained in the way of concluding the TPP. A potential deal-breaker for Australia was intellectual property protections for biologics.
If the proposals are agreed, they could delay the market entry of generic medicines in the region – and the impact will be felt around the world.
Seven rounds of negotiations for the Regional Comprehensive Economic Partnership have already taken place with virtually no public debate. The next round of negotiations begins today in Kyoto, Japan.
Generic medicines may have a different colour, shape, size and taste than the original brand.
Generic medicine contains the same active ingredient in the same dose as the original brand.
Generics aren’t always so cheap.
Pill bottles via bikeriderlondon/Shutterstock
More than eight out of every 10 prescriptions dispensed in the US is generic. This growth is due to a large number of top-selling drugs going off patent over the past decade, as well as innovations in…
Drug companies invent hundreds of new molecules that they hope to turn into saleable medicines.
Gone are the good old days when medicines had simple, easy to pronounce names such as aspirin, paracetamol and morphine. Nowadays pharmaceutical companies almost seem to revel in giving drugs names that…
Harder times ahead for Pfizer as Viagra patents end.
Those for whom Viagra is indispensable might be a little surprised that the ubiquitous blue, diamond-shaped pill was a chance discovery by a group of research pharmaceutical chemists at Pfizer’s research…
A Greens/EFA MEPs protest against ACTA at the European Parliament in Strasbourg. The protestors urged their fellow members to join them in standing up for democracy and a free internet.
©Photo European Union
The Anti-Counterfeiting Trade Agreement (ACTA) 2011 - Twitter hashtag #ACTA - is a controversial trade agreement designed to provide for stronger enforcement of intellectual property rights. There’s been…